Enovis (ENOV) Shares Slump 16% Over Six Months, Analysts Cite Weak Sales, Negative Returns

Enovis Corporation (ENOV) shares have dropped 16.1% over the past six months to $22.66 as of June 5, 2026, a sharp contrast to the S&P 500's 10% gain, prompting caution from analysts who flag persistent sales declines and poor capital returns. The company's sales fell at a 2.3% annual rate over the past five years, signaling weak demand. Its five-year average return on invested capital (ROIC) was negative 12.1%, indicating management lost money while expanding. The ROIC trend has also declined, suggesting few profitable growth opportunities. Trading at a forward price-to-earnings ratio of 5.7x, Enovis appears optically cheap, but analysts warn the valuation masks shaky fundamentals. The stock's recent decline does not guarantee a bottom, and potential downside remains substantial.